MiNK Therapeutics
INKT
MiNK Therapeutics (INKT) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.62
- EPS estimate
- −$0.60
- EPS surprise
- −3.33%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 13, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | −$0.60 | −$0.62 | −3.33% | $0.00 | SEC |
| Q1 2026 | May 15, 2026 | −$0.77 | −$0.57 | +25.97% | $0.00 | SEC |
| Q4 2025 | Mar 31, 2026 | −$0.68 | −$0.52 | +23.53% | $0.00 | SEC |
| Q3 2025 | Nov 14, 2025 | −$0.86 | −$0.65 | +23.98% | $0.00 | SEC |
| Q2 2025 | Aug 14, 2025 | −$0.55 | −$1.06 | −93.89% | $0.00 | SEC |
| Q1 2025 | May 15, 2025 | −$0.61 | −$0.70 | −15.19% | $0.00 | SEC |
| Q4 2024 | Mar 18, 2025 | −$0.49 | −$0.62 | −27.39% | $0.00 | SEC |
| Q3 2024 | Nov 14, 2024 | −$0.80 | −$0.50 | +37.55% | $0.00 | SEC |
| Q2 2024 | Aug 13, 2024 | −$0.98 | −$0.70 | +28.70% | $0.00 | SEC |
| Q1 2024 | May 14, 2024 | −$1.53 | −$1.10 | +27.87% | $0.00 | SEC |
| Q4 2023 | Mar 21, 2024 | −$1.53 | −$1.60 | −4.92% | $0.00 | SEC |
| Q3 2023 | Nov 9, 2023 | −$1.82 | −$1.50 | +17.39% | $0.00 | SEC |
| Q2 2023 | Aug 10, 2023 | −$1.98 | −$1.80 | +8.86% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$2.38 | −$1.70 | +28.56% | $0.00 | SEC |
| Q4 2022 | Mar 21, 2023 | −$2.10 | −$2.30 | −9.66% | $0.00 | SEC |
| Q3 2022 | Nov 3, 2022 | −$2.26 | −$1.90 | +15.93% | $0.00 | — |
| Q2 2022 | Aug 9, 2022 | −$2.33 | −$1.80 | +22.58% | $0.00 | — |
| Q1 2022 | May 10, 2022 | −$2.07 | −$2.30 | −11.29% | $0.00 | — |
| Q4 2021 | Mar 18, 2022 | −$4.10 | −$1.80 | +56.10% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did MiNK Therapeutics (INKT) last report earnings?
MiNK Therapeutics last reported on Aug 13, 2026, covering fiscal Q2 2026.
Did INKT beat earnings estimates?
No. MiNK Therapeutics reported EPS of −$0.62 for Q2 2026 against a −$0.60 estimate — a 3.33% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.